| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.38M | 17.71M | 19.96M | 12.11M | 9.93M | 10.96M |
| Gross Profit | 16.25M | 17.19M | 19.40M | 11.71M | 9.73M | 10.73M |
| EBITDA | 4.78M | 5.17M | 6.11M | 1.06M | 713.00K | 1.91M |
| Net Income | 3.63M | 4.05M | 6.02M | 1.31M | 723.00K | 1.53M |
Balance Sheet | ||||||
| Total Assets | 25.59M | 28.69M | 25.69M | 17.44M | 12.93M | 13.01M |
| Cash, Cash Equivalents and Short-Term Investments | 17.82M | 18.67M | 17.23M | 8.33M | 7.79M | 8.03M |
| Total Debt | 1.15M | 619.00K | 804.00K | 465.00K | 756.00K | 1.11M |
| Total Liabilities | 9.13M | 11.66M | 12.52M | 10.41M | 7.42M | 8.26M |
| Stockholders Equity | 16.46M | 17.03M | 13.18M | 7.03M | 5.51M | 4.75M |
Cash Flow | ||||||
| Free Cash Flow | 4.33M | 2.30M | 9.27M | 2.79M | 77.00K | 4.14M |
| Operating Cash Flow | 4.45M | 2.88M | 9.63M | 2.86M | 110.00K | 4.24M |
| Investing Cash Flow | -395.00K | -856.00K | -358.00K | -2.08M | -33.00K | -95.00K |
| Financing Cash Flow | -2.47M | -529.00K | -333.00K | -294.00K | -372.00K | -791.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £63.09M | 3.74 | 35.56% | 4.16% | ― | ― | |
70 Outperform | £78.39M | 54.18 | 2.93% | ― | -3.95% | 16.87% | |
70 Outperform | £449.89M | 71.10 | 1.53% | 1.73% | -0.18% | 11.49% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | £46.63M | 20.75 | 21.69% | ― | -19.19% | -41.12% | |
54 Neutral | £324.83M | 26.54 | 7.75% | 2.16% | ― | ― | |
41 Neutral | £13.27M | -35.35 | -19.77% | ― | ― | ― |